tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Advertisement

Elite Pharmaceuticals (ELTP) Revenue

Compare
336 Followers

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had a revenue of 32.00M in the quarter ending Mar 31, 2025, with 122.75%. This bring the company's revenue in the last twelve months to 84.04M, Decreased 20.07%. In the fiscal year ending Mar 31, 2025, Elite Pharmaceuticals had annual revenue of 84.04M with 48.42% growth.
Revenue (ttm)
84.04M
Revenue Growth
48.42%
P/S Ratio
6.84
Revenue/Employee
$1,313,186
Employees
64
Market Cap
$575.05M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
84.04M27.42M+48.42%
Mar 31, 2024
56.63M-34.10B-99.83%
Mar 31, 2023
34.16B34.12B+105,767.55%
Mar 31, 2022
32.26M6.88M+27.11%
Mar 31, 2021
25.38M7.39M+41.05%
Mar 31, 2020
17.99M10.43M+137.76%
Mar 31, 2019
7.57M109.80K+1.47%
Mar 31, 2018
7.46M-2.18M-22.61%
Mar 31, 2017
9.64M-2.86M-22.89%
Mar 31, 2016
12.50M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis